Literature DB >> 11409873

Transport of fluorescein in MDCKII-MRP1 transfected cells and mrp1-knockout mice.

H Sun1, D R Johnson, R A Finch, A C Sartorelli, D W Miller, W F Elmquist.   

Abstract

The multidrug resistant-associated protein 1 (MRP1) is a membrane-bound transport protein that is involved in the efflux of organic anions and has been implicated in multidrug resistance in cancer. MRP1 has also been reported to be ubiquitously expressed in normal tissues, including the brain. The presence of functional organic anion transporters in the blood-brain and blood-CSF barriers that influence the distribution of various compounds to the brain has long been known. The purpose of this study was to examine the role of MRP1 in the brain distribution of a model organic anion, fluorescein. The substrate specificity of MRP1 for fluorescein was initially determined by examining the accumulation of fluorescein in MDCKII MRP1-transfected cells. The distribution of fluorescein in the brain was then examined in wild-type and mrp1 gene knockout mice. The results show that in MDCKII MRP1-transfected cells, the accumulation of fluorescein was significantly lower (about 40% lower) than that in wild-type MDCKII cells. MRP1 inhibitors such as probenecid, MK-571, and LY402913 enhanced fluorescein accumulation in MDCKII MRP1-transfected cells to a greater extent than in wild-type MDCKII cells. In an in vivo study, after intravenous injection of fluorescein, the fluorescein brain-to-plasma concentration ratio in mrp1 knockout mice was not significantly different than that in wild-type mice. However, when probenecid was co-administered with fluorescein in wild-type mice, the fluorescein brain-to-plasma ratio was significantly increased (1.5-fold). These findings suggest that fluorescein is a substrate for MRP1. Furthermore, the in vivo study also suggests that MRP1 has a limited role in the transport and distribution of fluorescein in the brain. Therefore, other organic anion transport proteins, including the various isoforms of the MRP family, may be responsible for the accumulation and transport of organic anions in the brain. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11409873     DOI: 10.1006/bbrc.2001.5062

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Multidrug resistance transporters in the olfactory receptor neurons of Xenopus laevis tadpoles.

Authors:  Ivan Manzini; Detlev Schild
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

Review 2.  Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  NeuroRx       Date:  2005-01

3.  Effect of probenecid on fluorescein transport in the central nervous system using in vitro and in vivo models.

Authors:  H Sun; D W Miller; W F Elmquist
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

Review 4.  Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.

Authors:  Sagar Agarwal; Ramola Sane; Rajneet Oberoi; John R Ohlfest; William F Elmquist
Journal:  Expert Rev Mol Med       Date:  2011-05-13       Impact factor: 5.600

5.  Proteasome regulator marizomib (NPI-0052) exhibits prolonged inhibition, attenuated efflux, and greater cytotoxicity than its reversible analogs.

Authors:  Amanda Obaidat; Jeffrey Weiss; Brett Wahlgren; Rama R Manam; Venkat R Macherla; Katherine McArthur; Ta-Hsiang Chao; Michael A Palladino; G Kenneth Lloyd; Barbara C Potts; Salvatore J Enna; Saskia T C Neuteboom; Bruno Hagenbuch
Journal:  J Pharmacol Exp Ther       Date:  2011-02-08       Impact factor: 4.030

Review 6.  PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.

Authors:  Severin Mairinger; Thomas Erker; Markus Muller; Oliver Langer
Journal:  Curr Drug Metab       Date:  2011-10       Impact factor: 3.731

7.  Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier.

Authors:  Daisuke Sugiyama; Hiroyuki Kusuhara; Yong-Joo Lee; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

8.  Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor.

Authors:  Gangadhar Sunkara; Surya P Ayalasomayajula; Jack DeRuiter; Uday B Kompella
Journal:  Brain Res Bull       Date:  2009-09-15       Impact factor: 4.077

9.  The role of multidrug resistance protein 1 (MRP1) in transport of fluorescent anions across the human erythrocyte membrane.

Authors:  B Rychlik; A Balcerczyk; A Klimczak; G Bartosz
Journal:  J Membr Biol       Date:  2003-05-15       Impact factor: 1.843

10.  In silico and in vitro modeling of hepatocyte drug transport processes: importance of ABCC2 expression levels in the disposition of carboxydichlorofluroscein.

Authors:  Katharine Howe; G Gordon Gibson; Tanya Coleman; Nick Plant
Journal:  Drug Metab Dispos       Date:  2008-11-20       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.